I’m interpreting this to mean that Amphastar got approval for all dosage forms of Lovenox, not just the vial formulations (which are commercially inconsequential). My initial reaction was the same as yours, FWIW.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”